MedTrace Logo

Closed-loop Insulin Delivery Systems in Pancreatic Diabetes

NCT06227650 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2024-04-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the metabolic and the safety outcomes in people living with pancreatic diabetes (pancreatitis or pancreatectomy-induced diabetes) and using a closed-loop insulin delivery systems ("artificial pancreas").

Conditions

  • Secondary Pancreatic Diabetes

Interventions

DEVICE

hybrid closed loop insulin delivery system

Patients with secondary pancreatic diabetes equipped with a hybrid closed loop insulin delivery device

Sponsors & Collaborators

  • Centre Hospitalier Sud Francilien

    lead OTHER

Principal Investigators

  • Alfred PENFORNIS, PHD · Centre Hospitalier Sud Francilien

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-06
Primary Completion
2024-04-05
Completion
2024-04-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06227650 on ClinicalTrials.gov